Immunogenetics of Sjogren's syndrome

被引:0
作者
Kassan, SS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
来源
ANNALES DE MEDECINE INTERNE | 1998年 / 149卷 / 01期
关键词
Sjogren's syndrome; HLA antigens; HLA-DQ alleles; HLA-DR3; Anti-Ro; Anti-La;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology for SS remains unknown where multifactorial influences contribute to the pathogenesis of subsequent development of the disease. The genetic influence Is also multifactorial and the data suggests a familial component indicative of autosomal-dominant genes as well as genetic contributions associated with class-I and class-II HLA alleles. Various auto-antibodies found with increased frequency in SS (anti-Re and anti-La) were shown to be associated with HLA class-II alleles at the DQA(1) and DQB(1) loci that mere also found to have in common specific amino acid residues (10). Ethnic groups have also been studied and show varying HLA associations with primary SS. Multiple ethnic groups, however, share a DQ allele supporting the idea that the majority of SS patients carry a common allele which may predispose to primary SS. In some cases, the HLA-DR antigen may be induced and cause to appear on epithelial cells where they present antigen to Co 4+ T-cells, which then go on to aid in the destruction of salivary gland epithelial cells specifically. The further elucidation of disease associations as well as possible immunogenetic pathogenic mechanisms may help to explain the causes for the development of various autoimmune diseases such as Sjogren's Syndrome. This may eventually result in the ability to immunomodulate these abnormal immune responses. In so doing, an approach to treatment by genetic engineering may also be possible once a further understanding of the genetic influences and mechanisms in the causation of autoimmune disease is further elucidated.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
[21]   Vasculitis in Sjogren's Syndrome [J].
Scofield, R. Hal .
CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (06) :482-488
[22]   Treatment of Sjogren's syndrome [J].
Saraux, A. .
REVUE DE MEDECINE INTERNE, 2010, 31 :S16-S17
[23]   Autoantibodies in Sjogren's Syndrome [J].
Fayyaz, Anum ;
Kurien, Biji T. ;
Scofield, R. Hal .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (03) :419-+
[24]   Primary Sjogren's syndrome [J].
Bowman, S. J. .
LUPUS, 2018, 27 :32-35
[25]   Immunopathogenesis of Sjogren's syndrome [J].
Borchers, AT ;
Naguwa, SM ;
Keen, CL ;
Gershwin, ME .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2003, 25 (01) :89-104
[26]   Epigenetics and Sjogren's Syndrome [J].
Le Dantec, Christelle ;
Varin, Marie-Michele ;
Brooks, Wesley H. ;
Pers, Jacques-Olivier ;
Youinou, Pierre ;
Renaudineau, Yves .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (10) :2046-2053
[27]   Juvenile Sjogren's Syndrome [J].
Haas, Johannes-Peter .
AKTUELLE RHEUMATOLOGIE, 2019, 44 (02) :102-108
[28]   Pathophysiology of Sjogren's syndrome [J].
Mariette, X .
ANNALES DE MEDECINE INTERNE, 2003, 154 (03) :157-168
[29]   Genes and Sjogren's Syndrome [J].
Cobb, Beth L. ;
Lessard, Christopher J. ;
Harley, John B. ;
Moser, Kathy L. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (04) :847-+
[30]   Histopathological differences between primary Sjogren's syndrome and Sjogren's syndrome accompanied by scleroderma [J].
Kucuk, Ulku ;
Sarioglu, Sulen ;
Cetin, Pinar ;
Sari, Ismail ;
Birlik, Merih .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (03) :319-322